Journal of Clinical Oncology and Cancer Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Clinical Oncology and Cancer Research 44 7897 074717

ONCOLYTIC VIRUS OPEN ACCESS JOURNALS

Cancer is that the leading explanation for death globally, with an estimated mortality of 9.6 million in 2018 (World Health Organization). Conventional cancer treatment regimens typically include one or more modality like surgery, radiotherapy and chemotherapy. However, with these treatments it becomes progressively harder to cure or prolong patient life if the cancer isn't diagnosed at a sufficiently early stage, has metastasized at secondary sites, and/or has relapsed into therapy-resistance after initial treatment. Currently available new therapies include immunotherapy, targeted therapy, hormone therapy, somatic cell therapy, engineered lymphocytes and, finally, virotherapy with oncolytic viruses (OVs). Among these, OVs have emerged as an exceedingly promising modality for cancer treatment supported their multi-mechanistic advantages against diverse sorts of cancer: the selective infection and killing of cancer cells, the power in some cases to focus on cancer at metastatic sites, the discharge of tumor-associated antigens, triggering of novel anti-tumor innate and adaptive immune responses, and therefore the activation and recruitment of immune cells into the tumor microenvironment (TME). Furthermore, genetic modification can further enhance the antitumor activity of the many OVs and thus increase the suitability for combination with conventional or newer therapies . The primary genetically modified OV, an engineered adenovirus named H101, was approved in China in 2005 for the treatment of head and neck cancer [8]. Recently, HSV-1 based Talimogene Laherparepvec (T-VEC) OV was approved in 2015 within the USA and Europe for the treatment of non-resectable metastatic melanoma.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Get the App